|
|
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
http://www.journalclub.org/vol2/a69.html
The idea behind immunotherapy is to boost a patient’s immune reaction to cancer cells.
http://www.cchs.net/health/health-info/docs/2700/2775.asp?index=10236
There is now convincing evidence that both the cellular and humoral arms of the immune system are capable of interacting with tumour cells.
http://bmb.oxfordjournals.org/cgi/content/abstract/64/1/181